M3rftk noor - Breast Cancer Awarness Session Minya Uni.pptx
•Download as PPTX, PDF•
0 likes•2 views
The document is a presentation intended for healthcare professionals that was created by the Faculty of Medicine at Minya University in Egypt. It contains educational and scientific materials about an unspecified medical topic. The document notes that any patient information shared will be reviewed according to local medical privacy guidance and that the presentation contains copyrighted images that were adapted from original sources with permission from Roche. Contact information is provided for reporting adverse events or product complaints related to Roche products.
Report
Share
Report
Share
Recommended
Intro
The document summarizes the Orthopaedic Trauma Association's Trauma and Fracture Care Residency Core Curriculum Lectures. It provides lectures to support comprehensive orthopaedic trauma resident education. The lectures are meant to be modified by educators and will be continually updated on the OTA website. The OTA thanks members who helped create this syllabus and acknowledges contributions from textbooks. It is recommended lectures be copied to one folder and file names/locations be consistent for links to work.
Brief introduction to information ecosystem x public health.pptx
This presentation provides an introduction to Information Ecosystem X, a framework for understanding how the information environment interacts with and affects public health systems. It covers several topics including the relationship between trust in health systems and recommendations and access to health services/information. The document also notes that health misinformation can affect all levels of society and outlines a taxonomy of intervention strategies to address misinformation.
Drug promotional literature
The document discusses issues related to drug promotion and marketing practices in India. Some key points:
- 11% of statements made by drug reps to clinicians have been found to be inaccurate, and only 25% of physicians are aware of incorrect information provided.
- Drug promotion aims to induce prescription and use of drugs and is defined broadly by WHO. In India, promotional materials are regulated by codes from DOP and OPPI.
- Promotional claims should be accurate, balanced, and substantiated by evidence. Superlatives like "safe" should be avoided. Overall, the accurate representation of drug benefits and risks is emphasized.
Pptonpromotionalliteraturefinal 170419114043
The document discusses issues related to drug promotion and marketing practices in India. It notes that 11% of statements made by medical representatives about drugs have been found to be inaccurate. Few physicians are aware of incorrect information provided. Drug promotion is defined as any activity aimed at inducing prescription or use of drugs. Regulations and codes like the IFPMA and OPPI codes aim to ensure promotional materials are truthful, accurate and not misleading. However, commercial pressures sometimes lead companies to use less ethical practices like exaggerating drug effectiveness or downplaying risks to influence prescribing. Strong regulation and compliance with codes is needed to improve standards of drug promotion in India.
BHITS Executive Summary 2019
BHI Therapeutic Sciences is seeking $2.5 million to initiate stem cell treatment operations in New Jersey and Texas and for general corporate purposes. The company was formed in 2017 to commercialize stem cell therapies for a variety of diseases without drugs or surgery. BHI's treatment procedures have been used in over 2,000 patients through affiliates and the funds will allow the company to expand its research and open new clinics. BHI has FDA approval to begin a Phase I stroke treatment trial and plans to charge $5,000 per patient for the three-dose regimen.
Malaria WHO 2021 guideline.pdf
The document provides guidelines from the World Health Organization (WHO) for malaria prevention and control. It recommends several vector control interventions for large-scale deployment, including pyrethroid-only long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) using a WHO-prequalified insecticide. It conditionally recommends pyrethroid-PBO nets and larviciding as supplementary measures in some settings. It recommends ensuring access to effective vector control through ITNs or IRS at optimal coverage levels for populations at risk of malaria.
About biomed grid
The Biomed Grid aims to publish scientific research papers on biomedical technology to advance healthcare. It focuses on how technology assists in medical scenarios and clinical research. The journal shares quality content with researchers, students, and professionals to further biomedical knowledge. It accepts articles, reviews, case studies, and other formats to disseminate insights broadly. The journal has a peer review process and makes research openly accessible online to benefit society.
Mandatory hippa and information security
This document provides an overview of organizational ethics, HIPAA, data security, and patient privacy policies for employees. It emphasizes the responsibility of employees to maintain clinical integrity, ensure privacy and confidentiality of patient information, and respect patient values. Employees are educated on proper uses and disclosures of protected health information according to HIPAA rules. The organization monitors internet usage and secures systems to protect electronic patient information, requiring authorization for certain disclosures and auditing access to patient data.
Recommended
Intro
The document summarizes the Orthopaedic Trauma Association's Trauma and Fracture Care Residency Core Curriculum Lectures. It provides lectures to support comprehensive orthopaedic trauma resident education. The lectures are meant to be modified by educators and will be continually updated on the OTA website. The OTA thanks members who helped create this syllabus and acknowledges contributions from textbooks. It is recommended lectures be copied to one folder and file names/locations be consistent for links to work.
Brief introduction to information ecosystem x public health.pptx
This presentation provides an introduction to Information Ecosystem X, a framework for understanding how the information environment interacts with and affects public health systems. It covers several topics including the relationship between trust in health systems and recommendations and access to health services/information. The document also notes that health misinformation can affect all levels of society and outlines a taxonomy of intervention strategies to address misinformation.
Drug promotional literature
The document discusses issues related to drug promotion and marketing practices in India. Some key points:
- 11% of statements made by drug reps to clinicians have been found to be inaccurate, and only 25% of physicians are aware of incorrect information provided.
- Drug promotion aims to induce prescription and use of drugs and is defined broadly by WHO. In India, promotional materials are regulated by codes from DOP and OPPI.
- Promotional claims should be accurate, balanced, and substantiated by evidence. Superlatives like "safe" should be avoided. Overall, the accurate representation of drug benefits and risks is emphasized.
Pptonpromotionalliteraturefinal 170419114043
The document discusses issues related to drug promotion and marketing practices in India. It notes that 11% of statements made by medical representatives about drugs have been found to be inaccurate. Few physicians are aware of incorrect information provided. Drug promotion is defined as any activity aimed at inducing prescription or use of drugs. Regulations and codes like the IFPMA and OPPI codes aim to ensure promotional materials are truthful, accurate and not misleading. However, commercial pressures sometimes lead companies to use less ethical practices like exaggerating drug effectiveness or downplaying risks to influence prescribing. Strong regulation and compliance with codes is needed to improve standards of drug promotion in India.
BHITS Executive Summary 2019
BHI Therapeutic Sciences is seeking $2.5 million to initiate stem cell treatment operations in New Jersey and Texas and for general corporate purposes. The company was formed in 2017 to commercialize stem cell therapies for a variety of diseases without drugs or surgery. BHI's treatment procedures have been used in over 2,000 patients through affiliates and the funds will allow the company to expand its research and open new clinics. BHI has FDA approval to begin a Phase I stroke treatment trial and plans to charge $5,000 per patient for the three-dose regimen.
Malaria WHO 2021 guideline.pdf
The document provides guidelines from the World Health Organization (WHO) for malaria prevention and control. It recommends several vector control interventions for large-scale deployment, including pyrethroid-only long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) using a WHO-prequalified insecticide. It conditionally recommends pyrethroid-PBO nets and larviciding as supplementary measures in some settings. It recommends ensuring access to effective vector control through ITNs or IRS at optimal coverage levels for populations at risk of malaria.
About biomed grid
The Biomed Grid aims to publish scientific research papers on biomedical technology to advance healthcare. It focuses on how technology assists in medical scenarios and clinical research. The journal shares quality content with researchers, students, and professionals to further biomedical knowledge. It accepts articles, reviews, case studies, and other formats to disseminate insights broadly. The journal has a peer review process and makes research openly accessible online to benefit society.
Mandatory hippa and information security
This document provides an overview of organizational ethics, HIPAA, data security, and patient privacy policies for employees. It emphasizes the responsibility of employees to maintain clinical integrity, ensure privacy and confidentiality of patient information, and respect patient values. Employees are educated on proper uses and disclosures of protected health information according to HIPAA rules. The organization monitors internet usage and secures systems to protect electronic patient information, requiring authorization for certain disclosures and auditing access to patient data.
Mandatory hippa and information security
This document provides an overview of organizational ethics, HIPAA compliance, data security, and privacy policies for employees. It emphasizes protecting patient privacy, maintaining integrity in healthcare services, and ensuring ethical and lawful practices. Key aspects covered include obtaining patient authorization for disclosure of health information, monitoring access to electronic systems, and educating employees on security protocols and their responsibilities to keep information confidential.
2 Ethical obligations in Clinical Optometry.pptx
Optometrists have ethical obligations to provide socially important healthcare services with theoretical knowledge and extensive training. Optometrists must maintain patient confidentiality, obtain informed consent, and treat all patients with dignity without discrimination. Optometrists should collaborate with other professionals through referrals and consultations when in the best interest of patients, participate in continuing education, and adhere to research ethics involving human subjects. The optometric oath outlines the commitment to prioritize patient health, provide competent and compassionate care, keep patient information private, and serve communities.
Decision Support System for clinical practice created on the basis of the Un...
The company Socmedica developing an expert system of decision support for medical information systems. The product is aimed at solving the problem of medical errors.
Ortho implants may get up to 50% cheaper
The cost of orthopaedic implants in India is expected to decrease by 40-50% as the government plans to implement price caps to make them more affordable. Currently, there are no price controls for medical devices like stents and implants, allowing excessive pricing. Hip and knee surgeries are out of reach for over 80% of patients due to the high costs of implants. The government will discuss price regulation for stents and implants with manufacturers and officials to potentially make changes like mandatory declaration of maximum retail and per-unit prices.
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
The document outlines the roles and responsibilities of sponsors according to ICH-GCP guidelines. It discusses that sponsors are responsible for initiating, managing, financing, and monitoring clinical trials. They must ensure trials are conducted according to GCP standards, applicable regulations, and the approved protocol. Sponsors are also responsible for safety monitoring, reporting adverse events, quality assurance, selecting and compensating investigators, and maintaining required trial documentation.
HIGHLIGHTED: Dissemination of Patient-Specific Information from Devices by De...
This is the highlighted version of FDA's Guidance for Industry: Dissemination of Patient-Specific Information from Devices by Device Manufacturers from June 2016.
When these guidances come out, I typically go through them and highlight the most relevant portions for those who need to skim through or refresh their memory.
Health technology
The document discusses health technology and health technology assessment. It begins by defining health, technology, and health technology. It then discusses how health technologies are used at various levels of healthcare. The purpose of health technology includes developing frameworks for safe services and technologies. Areas of health technology include essential medicines and medical devices. Health technology assessment systematically evaluates health technologies and informs policymaking. It discusses the steps, purposes, and expertise involved in health technology assessment. The document also discusses health technologies and decision making, analyzing barriers and facilitators of evidence-based decision making in healthcare. It provides an example of a research article on physicians' and students' strategies for health information seeking after introducing digital libraries and technologies in Iranian hospitals.
Accelerating Clinical Research For Inclusive Development
The document summarizes challenges facing clinical research in India, including a lack of universal healthcare access, low participation in clinical trials, and issues with ethics committees. It outlines steps to make research more inclusive, such as regulatory approvals, informed consent processes, and safety monitoring. However, it notes that ethics committees lack independent oversight and accountability. For research to progress ethically, it recommends improving training, transparency, and preventing conflicts of interest.
Belgium Regulatory Agency for New Drug Submissions 2014
Belgium Regulatory Agency for New Drug Submissions 2014Pharmaceutical Compliance Inspection unit, Crown College of Canada
The Federal Agency for Medicines and Health Products (FAMHP) is the competent authority responsible for the quality, safety and efficacy of medicines and health products in Belgium. It ensures medicines and health products are authorized and used properly from development through post-marketing. Key activities include clinical trial authorization, marketing authorization, production inspections, pharmacovigilance, and ensuring proper use. Applicants can request scientific-technical advice from FAMHP to facilitate drug development and availability of innovative treatments for patients. Advice requests require supporting documentation and a fee and are reviewed within defined timelines depending on type.Ph rma principlesforresponsibleclinicaltrialdatasharing
The document outlines commitments by biopharmaceutical companies to responsibly share clinical trial data with qualified researchers and the public. The key commitments are:
1) Sharing patient-level data, study-level data, and protocols with qualified researchers upon request to facilitate legitimate research. Requests will be reviewed by a scientific board.
2) Making clinical study report synopses publicly available after drug approval to help patients and doctors understand trial results. Full reports may also be shared with researchers.
3) Informing trial patients about results in a factual summary developed with regulators.
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
In this presentation, you will find:
An introduction to the PharmaLedger project presented by Maria Eugenia (Xenia) Beltran | Project Coordinator / DRA and Use Case co-lead (Universidad Politécnica de Madrid)
Topic 1 | Clinical Trial eRecruitment | Despina Daliani (Onorach) and Ken Nessel (Pfizer)
Topic 2 | Clinical Trial eConsent | Hernando C. Giraldo (Boehringer Ingelheim) and Despina Daliani (Onorach)
Topic 3 | Health Data IoT Medical Device | Disa Lee Choun (UCB) and Francesca Rocchi (Bambino Gesù Children Hospital)
Topic 4 | Health Data Personalised Medicine | Beatriz Merino (Universidad Politécnica de Madrid) and Christos Kontogiorgis (Democritus University of Thrace)
You can also learn more about our #2 Open Webinar on Clinical Trials & Health Data by rewatching our video recording including the Q&A by clicking on the button below:
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
Health Informatics, ambiquitous Devices for Health Monitoring
Health monitoring devices, Cloud application technologies helping Chronic Patients for Regular monitoring. Specially Diabeties, Cancer, High Blood pressures.
The Mexico City Principles
The interaction between healthcare professionals and the pharmaceutical industry has been under close scrutiny lately both locally and internationally and has become vulnerable to numerous sources of conflicts of interest and unethical behavior. These conflicts may be subtle and difficult to identify but may create a strain in the relationship and subject either party to unjust and unethical demands. Though some actions may be done in good faith, such demands may cast doubt on the integrity of the medical profession especially if the primary interest of the patients is compromised. In some instances, even traditional or cultural practices considered appropriate before, may now be perceived globally as inappropriate and unethical.
Therefore, in order to protect the integrity of the medical profession, ethical interactions between healthcare professionals and other stakeholders must be ensured at all times so that medical decisions are made in the best interest of patients. The Mexico City Principles (MCP), was an initiative of the Asia Pacific Economic Cooperation (APEC) for small and medium enterprises (SMEs) endorsed by the APEC Ministers during their Ministerial Meeting in Hawaii in 2011. This is a Code of Ethics that defines how companies in the biopharmaceutical sector shall market, distribute, promote and advertise their products. These companies must adhere to the highest standards of ethical practice and ensure that all interactions with the healthcare professionals are governed by their mutual desire to address solely the patients’ medical needs.
The Code is governed by six underlying principles, namely:
a) Healthcare and Patient Focus- means everything we do is intended to benefit patients;
b) Integrity- means dealing ethically, honestly and respectfully in everything we do;
c) Independence- means to respect the need of autonomous decision-making of all parties, free from improper influence;
d) Legitimate Intent means everything we do is for the right reasons, is lawful and aligns with the spirit and the values of these Principles;
e) Transparency – means a general willingness to be open about our actions while respecting legitimate commercial sensitivities and intellectual property rights; and
f) Accountability – means a willingness to be responsible for our actions and interactions.
CV TRAN CHUNG THUY
Tran Chung Thuy is a medical doctor seeking a position in medical affairs, medical science liaison, or product management. He has over 15 years of experience in clinical practice and the pharmaceutical industry, most recently as an MSL at Hoffmann-La Roche promoting hepatitis, anemia, rheumatoid arthritis, and transplantation products. He is proficient in English and Vietnamese and has a strong track record of building relationships with key opinion leaders and external stakeholders.
Websites for Orthopedics
The document discusses how an orthopedic doctor can benefit from having a website. It notes that a website can serve as a source of knowledge by sharing information about orthopedic instruments, surgical techniques, and latest news and developments. It can also help share knowledge with other doctors and patients, offer additional services like online consultations and health tips, and guide and connect with patients and other medical professionals. The document recommends Plus91 Technologies for building customized orthopedic websites that can integrate with electronic medical record systems and provide patient portals.
Q1-Health P1.Consumer Health / Healthcare professional
The teenager bought two "health rings" from a company at the market that claimed they could detect mood and lower blood pressure, but after a week he and his sister developed rashes from rust on the rings. As a result, the teenager wants to file a complaint to get his money back for the ineffective products. Proper evaluation of health information and products is important to avoid unreliable claims and potential harm.
L20 financial issues in healthcare
This document discusses financial issues doctors may encounter and provides guidance. It addresses fees, private practice, advertising, media appearances, and gifts. Doctors can accept fair fees, but not coerce patients or prioritize personal interests. Private work should not interfere with public duties. Advertising oneself is prohibited except as allowed. Small gifts expressing goodwill are acceptable, but expensive gifts or those from companies could influence decisions and are not permitted. Doctors should abide by laws and ethical standards regarding financial matters in clinical practice.
L20 Financial issues in healthcare: Ethical and Legal Issues
This lecture is based on the Saudi Code of Ethics regarding the ethical and legal aspects related to the financial issues in health care, namely: Healthcare Practitioner’s Fee, Practicing in Private Sector, Participation in the Media, Gifts and Benefits, and the Relationships with Pharmaceutical and Medical Equipment and Companies.
This was presented to Alfarabi Medical College level 5 students as part of the Medical Ethics & Professionalism Course (30-4-2017)
Criticism of drug promotional literature(dpl)
This document discusses drug promotional literature and provides guidelines for its evaluation. It begins with an introduction on the large amount of drug information physicians receive. It then discusses the methods companies use to promote drugs, including detailing, literature, and gifts. Key points made are that drug promotion aims to induce prescription over educate and often includes inaccurate information. The document reviews sources physicians use, regulatory codes from WHO and India, and criteria for promotional materials. It emphasizes the need for physicians to critically evaluate promotional claims using scientific evidence.
HIPAA
The document provides an overview of the Health Insurance Portability and Accountability Act (HIPAA) including what information it protects, the entities it covers, and requirements for things like privacy practices, consent, and authorization. Central Michigan University is described as a "hybrid entity" under HIPAA, with some departments fully covered and others only indirectly affected. The presentation aims to familiarize staff with HIPAA regulations and the university's policies and procedures for protecting health information.
More Related Content
Similar to M3rftk noor - Breast Cancer Awarness Session Minya Uni.pptx
Mandatory hippa and information security
This document provides an overview of organizational ethics, HIPAA compliance, data security, and privacy policies for employees. It emphasizes protecting patient privacy, maintaining integrity in healthcare services, and ensuring ethical and lawful practices. Key aspects covered include obtaining patient authorization for disclosure of health information, monitoring access to electronic systems, and educating employees on security protocols and their responsibilities to keep information confidential.
2 Ethical obligations in Clinical Optometry.pptx
Optometrists have ethical obligations to provide socially important healthcare services with theoretical knowledge and extensive training. Optometrists must maintain patient confidentiality, obtain informed consent, and treat all patients with dignity without discrimination. Optometrists should collaborate with other professionals through referrals and consultations when in the best interest of patients, participate in continuing education, and adhere to research ethics involving human subjects. The optometric oath outlines the commitment to prioritize patient health, provide competent and compassionate care, keep patient information private, and serve communities.
Decision Support System for clinical practice created on the basis of the Un...
The company Socmedica developing an expert system of decision support for medical information systems. The product is aimed at solving the problem of medical errors.
Ortho implants may get up to 50% cheaper
The cost of orthopaedic implants in India is expected to decrease by 40-50% as the government plans to implement price caps to make them more affordable. Currently, there are no price controls for medical devices like stents and implants, allowing excessive pricing. Hip and knee surgeries are out of reach for over 80% of patients due to the high costs of implants. The government will discuss price regulation for stents and implants with manufacturers and officials to potentially make changes like mandatory declaration of maximum retail and per-unit prices.
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
The document outlines the roles and responsibilities of sponsors according to ICH-GCP guidelines. It discusses that sponsors are responsible for initiating, managing, financing, and monitoring clinical trials. They must ensure trials are conducted according to GCP standards, applicable regulations, and the approved protocol. Sponsors are also responsible for safety monitoring, reporting adverse events, quality assurance, selecting and compensating investigators, and maintaining required trial documentation.
HIGHLIGHTED: Dissemination of Patient-Specific Information from Devices by De...
This is the highlighted version of FDA's Guidance for Industry: Dissemination of Patient-Specific Information from Devices by Device Manufacturers from June 2016.
When these guidances come out, I typically go through them and highlight the most relevant portions for those who need to skim through or refresh their memory.
Health technology
The document discusses health technology and health technology assessment. It begins by defining health, technology, and health technology. It then discusses how health technologies are used at various levels of healthcare. The purpose of health technology includes developing frameworks for safe services and technologies. Areas of health technology include essential medicines and medical devices. Health technology assessment systematically evaluates health technologies and informs policymaking. It discusses the steps, purposes, and expertise involved in health technology assessment. The document also discusses health technologies and decision making, analyzing barriers and facilitators of evidence-based decision making in healthcare. It provides an example of a research article on physicians' and students' strategies for health information seeking after introducing digital libraries and technologies in Iranian hospitals.
Accelerating Clinical Research For Inclusive Development
The document summarizes challenges facing clinical research in India, including a lack of universal healthcare access, low participation in clinical trials, and issues with ethics committees. It outlines steps to make research more inclusive, such as regulatory approvals, informed consent processes, and safety monitoring. However, it notes that ethics committees lack independent oversight and accountability. For research to progress ethically, it recommends improving training, transparency, and preventing conflicts of interest.
Belgium Regulatory Agency for New Drug Submissions 2014
Belgium Regulatory Agency for New Drug Submissions 2014Pharmaceutical Compliance Inspection unit, Crown College of Canada
The Federal Agency for Medicines and Health Products (FAMHP) is the competent authority responsible for the quality, safety and efficacy of medicines and health products in Belgium. It ensures medicines and health products are authorized and used properly from development through post-marketing. Key activities include clinical trial authorization, marketing authorization, production inspections, pharmacovigilance, and ensuring proper use. Applicants can request scientific-technical advice from FAMHP to facilitate drug development and availability of innovative treatments for patients. Advice requests require supporting documentation and a fee and are reviewed within defined timelines depending on type.Ph rma principlesforresponsibleclinicaltrialdatasharing
The document outlines commitments by biopharmaceutical companies to responsibly share clinical trial data with qualified researchers and the public. The key commitments are:
1) Sharing patient-level data, study-level data, and protocols with qualified researchers upon request to facilitate legitimate research. Requests will be reviewed by a scientific board.
2) Making clinical study report synopses publicly available after drug approval to help patients and doctors understand trial results. Full reports may also be shared with researchers.
3) Informing trial patients about results in a factual summary developed with regulators.
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
In this presentation, you will find:
An introduction to the PharmaLedger project presented by Maria Eugenia (Xenia) Beltran | Project Coordinator / DRA and Use Case co-lead (Universidad Politécnica de Madrid)
Topic 1 | Clinical Trial eRecruitment | Despina Daliani (Onorach) and Ken Nessel (Pfizer)
Topic 2 | Clinical Trial eConsent | Hernando C. Giraldo (Boehringer Ingelheim) and Despina Daliani (Onorach)
Topic 3 | Health Data IoT Medical Device | Disa Lee Choun (UCB) and Francesca Rocchi (Bambino Gesù Children Hospital)
Topic 4 | Health Data Personalised Medicine | Beatriz Merino (Universidad Politécnica de Madrid) and Christos Kontogiorgis (Democritus University of Thrace)
You can also learn more about our #2 Open Webinar on Clinical Trials & Health Data by rewatching our video recording including the Q&A by clicking on the button below:
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
Health Informatics, ambiquitous Devices for Health Monitoring
Health monitoring devices, Cloud application technologies helping Chronic Patients for Regular monitoring. Specially Diabeties, Cancer, High Blood pressures.
The Mexico City Principles
The interaction between healthcare professionals and the pharmaceutical industry has been under close scrutiny lately both locally and internationally and has become vulnerable to numerous sources of conflicts of interest and unethical behavior. These conflicts may be subtle and difficult to identify but may create a strain in the relationship and subject either party to unjust and unethical demands. Though some actions may be done in good faith, such demands may cast doubt on the integrity of the medical profession especially if the primary interest of the patients is compromised. In some instances, even traditional or cultural practices considered appropriate before, may now be perceived globally as inappropriate and unethical.
Therefore, in order to protect the integrity of the medical profession, ethical interactions between healthcare professionals and other stakeholders must be ensured at all times so that medical decisions are made in the best interest of patients. The Mexico City Principles (MCP), was an initiative of the Asia Pacific Economic Cooperation (APEC) for small and medium enterprises (SMEs) endorsed by the APEC Ministers during their Ministerial Meeting in Hawaii in 2011. This is a Code of Ethics that defines how companies in the biopharmaceutical sector shall market, distribute, promote and advertise their products. These companies must adhere to the highest standards of ethical practice and ensure that all interactions with the healthcare professionals are governed by their mutual desire to address solely the patients’ medical needs.
The Code is governed by six underlying principles, namely:
a) Healthcare and Patient Focus- means everything we do is intended to benefit patients;
b) Integrity- means dealing ethically, honestly and respectfully in everything we do;
c) Independence- means to respect the need of autonomous decision-making of all parties, free from improper influence;
d) Legitimate Intent means everything we do is for the right reasons, is lawful and aligns with the spirit and the values of these Principles;
e) Transparency – means a general willingness to be open about our actions while respecting legitimate commercial sensitivities and intellectual property rights; and
f) Accountability – means a willingness to be responsible for our actions and interactions.
CV TRAN CHUNG THUY
Tran Chung Thuy is a medical doctor seeking a position in medical affairs, medical science liaison, or product management. He has over 15 years of experience in clinical practice and the pharmaceutical industry, most recently as an MSL at Hoffmann-La Roche promoting hepatitis, anemia, rheumatoid arthritis, and transplantation products. He is proficient in English and Vietnamese and has a strong track record of building relationships with key opinion leaders and external stakeholders.
Websites for Orthopedics
The document discusses how an orthopedic doctor can benefit from having a website. It notes that a website can serve as a source of knowledge by sharing information about orthopedic instruments, surgical techniques, and latest news and developments. It can also help share knowledge with other doctors and patients, offer additional services like online consultations and health tips, and guide and connect with patients and other medical professionals. The document recommends Plus91 Technologies for building customized orthopedic websites that can integrate with electronic medical record systems and provide patient portals.
Q1-Health P1.Consumer Health / Healthcare professional
The teenager bought two "health rings" from a company at the market that claimed they could detect mood and lower blood pressure, but after a week he and his sister developed rashes from rust on the rings. As a result, the teenager wants to file a complaint to get his money back for the ineffective products. Proper evaluation of health information and products is important to avoid unreliable claims and potential harm.
L20 financial issues in healthcare
This document discusses financial issues doctors may encounter and provides guidance. It addresses fees, private practice, advertising, media appearances, and gifts. Doctors can accept fair fees, but not coerce patients or prioritize personal interests. Private work should not interfere with public duties. Advertising oneself is prohibited except as allowed. Small gifts expressing goodwill are acceptable, but expensive gifts or those from companies could influence decisions and are not permitted. Doctors should abide by laws and ethical standards regarding financial matters in clinical practice.
L20 Financial issues in healthcare: Ethical and Legal Issues
This lecture is based on the Saudi Code of Ethics regarding the ethical and legal aspects related to the financial issues in health care, namely: Healthcare Practitioner’s Fee, Practicing in Private Sector, Participation in the Media, Gifts and Benefits, and the Relationships with Pharmaceutical and Medical Equipment and Companies.
This was presented to Alfarabi Medical College level 5 students as part of the Medical Ethics & Professionalism Course (30-4-2017)
Criticism of drug promotional literature(dpl)
This document discusses drug promotional literature and provides guidelines for its evaluation. It begins with an introduction on the large amount of drug information physicians receive. It then discusses the methods companies use to promote drugs, including detailing, literature, and gifts. Key points made are that drug promotion aims to induce prescription over educate and often includes inaccurate information. The document reviews sources physicians use, regulatory codes from WHO and India, and criteria for promotional materials. It emphasizes the need for physicians to critically evaluate promotional claims using scientific evidence.
HIPAA
The document provides an overview of the Health Insurance Portability and Accountability Act (HIPAA) including what information it protects, the entities it covers, and requirements for things like privacy practices, consent, and authorization. Central Michigan University is described as a "hybrid entity" under HIPAA, with some departments fully covered and others only indirectly affected. The presentation aims to familiarize staff with HIPAA regulations and the university's policies and procedures for protecting health information.
Similar to M3rftk noor - Breast Cancer Awarness Session Minya Uni.pptx (20)
Decision Support System for clinical practice created on the basis of the Un...
Decision Support System for clinical practice created on the basis of the Un...
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
HIGHLIGHTED: Dissemination of Patient-Specific Information from Devices by De...
HIGHLIGHTED: Dissemination of Patient-Specific Information from Devices by De...
Accelerating Clinical Research For Inclusive Development
Accelerating Clinical Research For Inclusive Development
Belgium Regulatory Agency for New Drug Submissions 2014
Belgium Regulatory Agency for New Drug Submissions 2014
Ph rma principlesforresponsibleclinicaltrialdatasharing
Ph rma principlesforresponsibleclinicaltrialdatasharing
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
Health Informatics, ambiquitous Devices for Health Monitoring
Health Informatics, ambiquitous Devices for Health Monitoring
Q1-Health P1.Consumer Health / Healthcare professional
Q1-Health P1.Consumer Health / Healthcare professional
L20 Financial issues in healthcare: Ethical and Legal Issues
L20 Financial issues in healthcare: Ethical and Legal Issues
More from IbrahemIssacGaied
STEmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmmmmmmmmmmmmmmmM CELL RESEARCH AND THE...
Mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmMmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm......................mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mm
Clinical ex.pptxmmmmmmmmmmmmmmmmmmmmmmmm
This document contains questions pertaining to the diagnosis and management of various clinical cases. It includes 10 slides with questions about cysts, lipomas, hernias, thyroid disorders, leg ulcers, abdominal masses, and breast examinations. The key topics covered are the pathognomonic features, common complications, differential diagnoses, and clinical findings and techniques for various clinical presentations.
hiatus hernia.pptxmmmmmmmmmmmmmmmmmmmmmmm.
A hiatus hernia occurs when part of the stomach protrudes through an enlarged opening in the diaphragm. There are two main types: sliding, where the esophagus-stomach junction slides up, and paraesophageal, where part of the stomach pushes through beside the esophagus. Risk factors include older age, obesity, and weak muscles. Symptoms are heartburn, regurgitation, difficulty swallowing, and chest pain. Diagnosis involves medical history, imaging like barium swallow, and endoscopy. Treatment options are lifestyle changes, medications like antacids or PPIs, and surgery to repair severe cases.
IBDs معدل.pptxmmmmmmmmmmmmmmmmmmmmmmmmmmm
The document outlines the agenda for an oncosurgical unit meeting at Minia University discussing inflammatory bowel diseases (IBDs) from surgical and oncological perspectives. The meeting will cover an introduction to IBDs, the epidemiology and pathophysiology of these conditions, the differences between Crohn's disease and ulcerative colitis, management and surgical considerations for IBDs, and the oncological risks factors and surveillance recommendations for patients with IBDs. The document provides a structured outline of the topics to be discussed at the meeting.
gastric cancer.pptxmmmmmmmmmmmmmmmmmmmmmmm
This document discusses gastric cancer (GAC). It notes that GAC is the 1st most common primary malignant tumor of the stomach, 2nd most common gastrointestinal tumor, and 3rd leading cause of cancer death worldwide. Risk factors for GAC include smoking, H. pylori infection, atrophic gastritis, and hereditary syndromes. Histologically, GAC is classified as intestinal type, diffuse type, or otherwise based on the Lauren classification system. Staging is done using the TNM system. Investigation involves endoscopy, biopsy, and imaging. Management depends on stage - early cancers receive gastrectomy and chemotherapy while advanced or metastatic cancers receive chemotherapy or palliative care.
HCC معدل .pptxmmmmmmmmmmmmmmmmmmmmmmmmmmmm
This document provides an overview of hepatocellular carcinoma (HCC) in Egypt, including treatment options and their selection criteria. The main treatment modalities discussed are resection, transplantation, radiofrequency ablation (RFA), transarterial chemoembolization (TACE), transarterial radio therapy (TART), yttrium-90 (Y-90) therapy, and stereotactic body radiation therapy (SBRT). Each treatment has specific criteria for patient eligibility and tumor characteristics, such as lesion size and location. The document compares advantages and disadvantages of the different treatments.
GIST.pptxmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm
GIST are rare mesenchymal tumors that arise from interstitial cells of Cajal in the gastrointestinal tract. They commonly express the receptor tyrosine kinases KIT or PDGFRA, which are often mutated. Complete surgical resection is the main treatment for localized primary GIST, while targeted therapy with imatinib or sunitinib is used for advanced or metastatic disease. Factors like tumor size, mitotic rate, and site of origin determine prognosis and risk of recurrence to guide adjuvant targeted therapy or surveillance after surgery.
liver disease presentation .pptxmmmmmmmmm
1. The liver and biliary ducts arise from a foregut diverticulum, with the cranial part forming the liver, caudal part forming the ventral pancreas, and intermediate bud forming the gallbladder.
2. The liver has 4 lobes and 8 segments, each supplied by its own branches of the hepatic artery, portal vein and bile duct, allowing surgical resection of individual segments.
3. Liver injuries are most often caused by blunt trauma or penetrating injuries, and may involve lacerations, hematomas or ruptures requiring laparotomy, suturing, and sometimes lobectomy or segmentectomy.
Cancer esophagus.pptxmmmmmmmmmmmmmmmmmmmmmmmmmm
Dr. Abdelrahman Salah is a lecturer in general surgery at an unnamed department. His area of expertise is cancer of the esophagus. The document provides his name, title, area of specialization within general surgery, and medical condition he treats.
meeting 22.pptxmmmmmmmmmmmmmmmmmmmmmmmmmm
Three patient cases were presented for discussion at an oncosurgical unit meeting:
1. A 25-year-old male with a history of laparoscopic total colectomy for FAP, presenting with recurrent bleeding per rectum and anemia. Colonoscopy and labs were unremarkable except for internal piles.
2. A 39-year-old male with a history of repeated vomiting. Endoscopy found an inflammatory ulcer with H. pylori and gastritis. CT scan showed GB stones, reduced aortomesenteric distance and angle, and scanty fat.
3. A 17-year-old female with abdominal pain. Imaging found a large pelviabdominal cyst
More from IbrahemIssacGaied (20)
STEmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmmmmmmmmmmmmmmmM CELL RESEARCH AND THE...
STEmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmmmmmmmmmmmmmmmM CELL RESEARCH AND THE...
Recently uploaded
Advanced Java[Extra Concepts, Not Difficult].docx
This is part 2 of my Java Learning Journey. This contains Hashing, ArrayList, LinkedList, Date and Time Classes, Calendar Class and more.
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
Denis is a dynamic and results-driven Chief Information Officer (CIO) with a distinguished career spanning information systems analysis and technical project management. With a proven track record of spearheading the design and delivery of cutting-edge Information Management solutions, he has consistently elevated business operations, streamlined reporting functions, and maximized process efficiency.
Certified as an ISO/IEC 27001: Information Security Management Systems (ISMS) Lead Implementer, Data Protection Officer, and Cyber Risks Analyst, Denis brings a heightened focus on data security, privacy, and cyber resilience to every endeavor.
His expertise extends across a diverse spectrum of reporting, database, and web development applications, underpinned by an exceptional grasp of data storage and virtualization technologies. His proficiency in application testing, database administration, and data cleansing ensures seamless execution of complex projects.
What sets Denis apart is his comprehensive understanding of Business and Systems Analysis technologies, honed through involvement in all phases of the Software Development Lifecycle (SDLC). From meticulous requirements gathering to precise analysis, innovative design, rigorous development, thorough testing, and successful implementation, he has consistently delivered exceptional results.
Throughout his career, he has taken on multifaceted roles, from leading technical project management teams to owning solutions that drive operational excellence. His conscientious and proactive approach is unwavering, whether he is working independently or collaboratively within a team. His ability to connect with colleagues on a personal level underscores his commitment to fostering a harmonious and productive workplace environment.
Date: May 29, 2024
Tags: Information Security, ISO/IEC 27001, ISO/IEC 42001, Artificial Intelligence, GDPR
-------------------------------------------------------------------------------
Find out more about ISO training and certification services
Training: ISO/IEC 27001 Information Security Management System - EN | PECB
ISO/IEC 42001 Artificial Intelligence Management System - EN | PECB
General Data Protection Regulation (GDPR) - Training Courses - EN | PECB
Webinars: https://pecb.com/webinars
Article: https://pecb.com/article
-------------------------------------------------------------------------------
For more information about PECB:
Website: https://pecb.com/
LinkedIn: https://www.linkedin.com/company/pecb/
Facebook: https://www.facebook.com/PECBInternational/
Slideshare: http://www.slideshare.net/PECBCERTIFICATION
Community pharmacy- Social and preventive pharmacy UNIT 5
Covered community pharmacy topic of the subject Social and preventive pharmacy for Diploma and Bachelor of pharmacy
How to Add Chatter in the odoo 17 ERP Module
In Odoo, the chatter is like a chat tool that helps you work together on records. You can leave notes and track things, making it easier to talk with your team and partners. Inside chatter, all communication history, activity, and changes will be displayed.
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityAkanksha trivedi rama nursing college kanpur.
Natural birth techniques are various type such as/ water birth , alexender method, hypnosis, bradley method, lamaze method etcPollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...National Information Standards Organization (NISO)
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS Template 2023-2024 by: Irene S. Rueco
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
This Dissertation explores the particular circumstances of Mirzapur, a region located in the
core of India. Mirzapur, with its varied terrains and abundant biodiversity, offers an optimal
environment for investigating the changes in vegetation cover dynamics. Our study utilizes
advanced technologies such as GIS (Geographic Information Systems) and Remote sensing to
analyze the transformations that have taken place over the course of a decade.
The complex relationship between human activities and the environment has been the focus
of extensive research and worry. As the global community grapples with swift urbanization,
population expansion, and economic progress, the effects on natural ecosystems are becoming
more evident. A crucial element of this impact is the alteration of vegetation cover, which plays a
significant role in maintaining the ecological equilibrium of our planet.Land serves as the foundation for all human activities and provides the necessary materials for
these activities. As the most crucial natural resource, its utilization by humans results in different
'Land uses,' which are determined by both human activities and the physical characteristics of the
land.
The utilization of land is impacted by human needs and environmental factors. In countries
like India, rapid population growth and the emphasis on extensive resource exploitation can lead
to significant land degradation, adversely affecting the region's land cover.
Therefore, human intervention has significantly influenced land use patterns over many
centuries, evolving its structure over time and space. In the present era, these changes have
accelerated due to factors such as agriculture and urbanization. Information regarding land use and
cover is essential for various planning and management tasks related to the Earth's surface,
providing crucial environmental data for scientific, resource management, policy purposes, and
diverse human activities.
Accurate understanding of land use and cover is imperative for the development planning
of any area. Consequently, a wide range of professionals, including earth system scientists, land
and water managers, and urban planners, are interested in obtaining data on land use and cover
changes, conversion trends, and other related patterns. The spatial dimensions of land use and
cover support policymakers and scientists in making well-informed decisions, as alterations in
these patterns indicate shifts in economic and social conditions. Monitoring such changes with the
help of Advanced technologies like Remote Sensing and Geographic Information Systems is
crucial for coordinated efforts across different administrative levels. Advanced technologies like
Remote Sensing and Geographic Information Systems
9
Changes in vegetation cover refer to variations in the distribution, composition, and overall
structure of plant communities across different temporal and spatial scales. These changes can
occur natural.
How to Setup Warehouse & Location in Odoo 17 Inventory
In this slide, we'll explore how to set up warehouses and locations in Odoo 17 Inventory. This will help us manage our stock effectively, track inventory levels, and streamline warehouse operations.
How to Fix the Import Error in the Odoo 17
An import error occurs when a program fails to import a module or library, disrupting its execution. In languages like Python, this issue arises when the specified module cannot be found or accessed, hindering the program's functionality. Resolving import errors is crucial for maintaining smooth software operation and uninterrupted development processes.
clinical examination of hip joint (1).pdf
described clinical examination all orthopeadic conditions .
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
Discover the Simplified Electron and Muon Model: A New Wave-Based Approach to Understanding Particles delves into a groundbreaking theory that presents electrons and muons as rotating soliton waves within oscillating spacetime. Geared towards students, researchers, and science buffs, this book breaks down complex ideas into simple explanations. It covers topics such as electron waves, temporal dynamics, and the implications of this model on particle physics. With clear illustrations and easy-to-follow explanations, readers will gain a new outlook on the universe's fundamental nature.
How to Make a Field Mandatory in Odoo 17
In Odoo, making a field required can be done through both Python code and XML views. When you set the required attribute to True in Python code, it makes the field required across all views where it's used. Conversely, when you set the required attribute in XML views, it makes the field required only in the context of that particular view.
Hindi varnamala | hindi alphabet PPT.pdf
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
How to Build a Module in Odoo 17 Using the Scaffold Method
Odoo provides an option for creating a module by using a single line command. By using this command the user can make a whole structure of a module. It is very easy for a beginner to make a module. There is no need to make each file manually. This slide will show how to create a module using the scaffold method.
Recently uploaded (20)
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
Community pharmacy- Social and preventive pharmacy UNIT 5
Community pharmacy- Social and preventive pharmacy UNIT 5
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
How to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 Inventory
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
M3rftk noor - Breast Cancer Awarness Session Minya Uni.pptx
- 1. M-EG-00001539 Presented by: Faculty of Medicine Minya University Sunday, 17th Dec 2023
- 2. HCP Own Material (Presentation) Materials and content included are intended for educational and scientific purpose for Health Care Care Professionals only, and were created according to the assessment and review of the participating disease area Expert with no influence of the sponsors or any other organization, any patient shared information to be reviewed according to the local guidance for sharing medical information Copyright Disclaimer All the figures and tables in this deck have been adapted from original sources and redrawn so as not to infringe on the copyright, except in cases where Roche owns the copyright. Permission has been obtained by Roche for the images included in this deck. Dear Recipient Notice on Copyright Restrictions The materials supplied to you are copyrighted. Roche has a license with the copyright holder to send you these materials for your exclusive use. You are not allowed to distribute these materials further. If you wish to do so, you will have to obtain your own license from the copyright holder. Any person who makes unauthorized copy or adaptation of the supplied materials may be liable for copyright infringement. M-EG-00001539 "In case of any adverse event or product complaint occurring with Roche product please forward details to egypt.drug-safety@roche.com, Fax:+2 (02) 23228866 or leave a voice mail at +2 (02) 23228855/52 & +202 01069990337.For medical information, please send an email to: egypt.medical-information@roche.com."
- 10. M-EG-00001539
- 11. M-EG-00001539
- 12. M-EG-00001539
- 13. M-EG-00001539
- 14. M-EG-00001539
- 15. M-EG-00001539
- 16. M-EG-00001539
- 17. M-EG-00001539
- 18. M-EG-00001539
- 19. M-EG-00001539
- 20. M-EG-00001539
- 21. M-EG-00001539
- 22. M-EG-00001539
- 23. M-EG-00001539
- 24. M-EG-00001539
- 25. M-EG-00001539
- 26. M-EG-00001539
- 27. M-EG-00001539
- 28. M-EG-00001539
- 29. M-EG-00001539
- 30. M-EG-00001539
- 31. M-EG-00001539
- 32. M-EG-00001539
- 33. M-EG-00001539
- 34. M-EG-00001539
- 35. M-EG-00001539
- 36. M-EG-00001539
- 37. M-EG-00001539
- 38. M-EG-00001539
- 39. M-EG-00001539